Clinical Trial Update: Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients After Switching to Tiotropium Plus Olodaterol Fixed Dose Combination in Greece

View source ↗

Summary

Quality-of-life outcomes were assessed in COPD patients switched to a tiotropium/olodaterol fixed-dose combination; the trial in Greece is completed and results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tiotropium/olodaterol fixed-dose combination (tiotropium/olodaterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Status: COMPLETED | Results posted: 2023-11-28